scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10792-018-0992-1 |
P698 | PubMed publication ID | 30043134 |
P2093 | author name string | Jing Guo | |
Xiaoxin Li | |||
Xiaoguang Cao | |||
P2860 | cites work | Therapeutic targets in age-related macular disease | Q24623107 |
Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis | Q34116888 | ||
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 | ||
A novel technique for choroidal fluid drainage in uveal effusion syndrome | Q34724236 | ||
Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment | Q41588526 | ||
Uveal effusion syndrome | Q43160546 | ||
The surgical management of uveal effusion syndrome | Q68943577 | ||
Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology | Q73535800 | ||
UVEAL EFFUSION. 1. CLINICAL PICTURE | Q76551602 | ||
Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis | Q84283942 | ||
Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model | Q88089018 | ||
P433 | issue | 8 | |
P304 | page(s) | 1885-1890 | |
P577 | publication date | 2018-07-24 | |
P1433 | published in | International Ophthalmology | Q15763839 |
P1476 | title | Partial thickness sclerectomy and intravitreal anti-VEGF therapy for intractable uveal effusion syndrome | |
P478 | volume | 39 |
Search more.